Globin Solutions, a poisoning antidote spinout from University of Pittsburgh, has closed more than $5m in series A funding with investors including UPMC Enterprises, the commercialisation arm of University of Pittsburgh Medical Center.

The round was led by Tus-S&T Service Group, a wholly-owned subsidiary of Tsinghua University’s enterprise arm, TusHoldings.

Globin Solutions is working on an antidote combatting severe carbon monoxide poisoning. A large intake of carbon monoxide can be fatal and can result from situations such as household fires.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?